About ICON plc ICON plc is a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries. The company specialises in the strategic ...

Icon is boosting its medical device and diagnostic research offering with a buyout deal for Parisian medtech CRO MedPass International. The deal, financial details of which were not disclosed ...

and medical review processes using AI and statistical modelling for faster, precise data delivery.” The two companies have worked together for over two decades, with Medidata supporting Icon in ...

ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the William Blair ...

ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It ...

BALLERUP, Denmark & DUBLIN--(BUSINESS WIRE)--LEO Pharma, a global leader in medical dermatology, and ICON plc (NASDAQ: ICLR) today announced a strategic partnership that will enable LEO Pharma to ...